Enovis Corporation reported an insider purchase this week as Chief Administrative Officer Oliver Engert picked up 1,000 shares of company stock on March 13, 2026, at a purchase price of $23.74 per share. The transaction was valued at $23,740 and raises Engert's direct ownership to 48,640 shares.
The insider buy occurred while Enovis shares trade near $23.21, a level considerably lower than the company's 52-week peak of $40.70. The share price has declined roughly 41% over the past year, underscoring the gap between current market value and last year's high-water mark.
Market commentary included an InvestingPro assessment that ENOV currently appears undervalued, with a Fair Value estimate that suggests upside potential at present trading levels. Investors interested in deeper analysis can consult the Pro Research Report available for ENOV and more than 1,400 other U.S. equities.
Separately, Enovis released its fourth-quarter 2025 financial results. Earnings per share for the quarter came in at $0.95, ahead of the consensus estimate of $0.82. Revenue for the same period totaled $575.7 million, which was slightly below the expected $584.71 million.
Management provided guidance for 2026 that contains a mix of signals relative to market expectations: revenue guidance is set below consensus, EBITDA is expected to be in line with consensus, and EPS guidance is projected to come in above consensus estimates.
Following the quarterly report, Needham adjusted its price target for Enovis upward to $52 from $49 while maintaining a Buy rating on the stock. Analysts and investors have pointed to the company’s profitability metrics and recent product initiatives as drivers behind the favorable reception to the earnings print.
Overall, the insider purchase by Engert and the company’s mixed quarterly performance have drawn attention. The transaction represents a direct, albeit modest, increase in an executive's stake, while the financial results and guidance present a mixed picture for investors weighing valuation, near-term revenue trajectory, and profitability outlook.
Summary: Oliver Engert bought 1,000 Enovis shares at $23.74 on March 13, 2026, bringing his direct holdings to 48,640 shares. The company reported Q4 2025 EPS of $0.95 versus a $0.82 forecast and revenue of $575.7 million versus an expected $584.71 million. Guidance for 2026 expects revenue below consensus, EBITDA in line, and EPS above consensus. Needham raised its price target to $52 and kept a Buy rating.